Cargando…

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

An updated meta-analysis incorporating nine randomized trials (n = 816) investigating low-to-moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome (ARDS) show moderate-to-high quality evidence that glucocorticoid therapy is safe and reduces (i) time to endotracheal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meduri, Gianfranco Umberto, Siemieniuk, Reed A. C., Ness, Rachel A., Seyler, Samuel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109298/ https://www.ncbi.nlm.nih.gov/pubmed/30155260 http://dx.doi.org/10.1186/s40560-018-0321-9

Ejemplares similares

Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
por: Schwingshackl, Andreas, et al.
Publicado: (2016)

Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2016)

Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2020)

Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS
por: Kimura, Dai, et al.
Publicado: (2016)

Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
por: Salton, Francesco, et al.
Publicado: (2023)

Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
por: Salton, Francesco, et al.
Publicado: (2020)

Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients
por: Saeed, Mohammed Abdel Monem, et al.
Publicado: (2022)

Diagnostic workup for ARDS patients
por: Papazian, Laurent, et al.
Publicado: (2016)

PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA
por: Szeto, C.H.
Publicado: (2019)

Protective effect of methylprednisolone on ventilator-induced diaphragm dysfunction is dose dependent
por: Maes, K, et al.
Publicado: (2010)

CMV reactivation caused by methylprednisolone therapy for ARDS after esophagectomy
por: Sato, Yusuke, et al.
Publicado: (2012)

Driving pressure is not associated with mortality in mechanically ventilated patients without ARDS
por: Lanspa, Michael J., et al.
Publicado: (2019)

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment
por: Umberto Meduri, Gianfranco, et al.
Publicado: (2011)

Prolonged use of noninvasive ventilation in the management of COVID-19-induced ARDS: a case report
por: Kandel, Ashim, et al.
Publicado: (2023)

CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
por: Blot, Mathieu, et al.
Publicado: (2020)

Prone Position Ventilation in Severe ARDS due to COVID-19: Comparison between Prolonged and Intermittent Strategies
por: Karlis, George, et al.
Publicado: (2023)

Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
por: Meduri, G. Umberto, et al.
Publicado: (2022)

Correction to: CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
por: Blot, Mathieu, et al.
Publicado: (2021)

IN-HOSPITAL MORTALITY IN MECHANICALLY VENTILATED PATIENTS WITH COVID-19 WITH DIFFERENT ARDS PHENOTYPES
por: LEE, JOOSEOB, et al.
Publicado: (2021)

Methylprednisolone/prednisolone: Prolongation of the lung injury healing: case report
Publicado: (2022)

ARDS before and after the start of mechanical ventilation
por: Anzueto, A, et al.
Publicado: (2000)

Intravenous perfluorocarbons for prevention of ventilator-associated ARDS
por: Scultetus, A, et al.
Publicado: (2013)

Optimizing Mechanical Ventilation in Refractory ARDS
por: Terzi, Nicolas, et al.
Publicado: (2022)

Early Hyperglycemia in Pediatric Traumatic Brain Injury Predicts for Mortality, Prolonged Duration of Mechanical Ventilation, and Intensive Care Stay
por: Chong, Shu-Ling, et al.
Publicado: (2015)

Early Elevation of Matrix Metalloproteinase-8 and -9 in Pediatric ARDS Is Associated with an Increased Risk of Prolonged Mechanical Ventilation
por: Kong, Michele Y. F., et al.
Publicado: (2011)

Developing an explainable machine learning model to predict the mechanical ventilation duration of patients with ARDS in intensive care units
por: Wang, Zichen, et al.
Publicado: (2023)

Rapid induction of autoantibodies during ARDS and septic shock
por: Burbelo, Peter D, et al.
Publicado: (2010)

Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy
por: Forel, Jean-Marie, et al.
Publicado: (2012)

Prolonged Prone Position Ventilation Is Associated With Reduced Mortality in Intubated COVID-19 Patients
por: Okin, Daniel, et al.
Publicado: (2023)

Mechanical ventilation in early COVID-19 ARDS
por: Lepper, Philipp M., et al.
Publicado: (2020)

COVID-19 ARDS: getting ventilation right
por: Pérez-Fernández, Xosé L, et al.
Publicado: (2022)

Does remifentanil shorten ventilator maintenance, midozolam prolong it, or both alter its duration?
por: Daniell, Harry W.
Publicado: (2009)

Pre-admission air pollution exposure prolongs the duration of ventilation in intensive care patients
por: De Weerdt, Annick, et al.
Publicado: (2020)

Machine learning based prediction of prolonged duration of mechanical ventilation incorporating medication data
por: Sikora, Andrea, et al.
Publicado: (2023)

Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
por: Salton, Francesco, et al.
Publicado: (2022)

Prolonged sedation in ARDS patients with inhaled anesthetics: our experience
por: Redaelli, S, et al.
Publicado: (2013)

Blood product transfusions in septic patients are associated with mortality, ARDS, and more days on mechanical ventilation
por: Dobesh, PP, et al.
Publicado: (2014)

Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality
por: Maamar, Adel, et al.
Publicado: (2023)

IMPACT OF VENTILATOR MODEL ON MORTALITY: A RETROSPECTIVE CROSS-SECTIONAL STUDY IN 147 MECHANICALLY VENTILATED PATIENTS WITH COVID-19 ARDS
por: Castaneda, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_83bri4u321v853nbsrr100ds57